Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms of the Female Genitalia”

3,363 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,363 results

Not applicableLooking for participantsNCT01601171
What this trial is testing

Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate

Who this might be right for
Kallmann SyndromeHypogonadotropic HypogonadismHypothalamic Amenorrhea+5 more
Centre Hospitalier Universitaire Vaudois 2,000
Large-scale testing (Phase 3)Active Not RecruitingNCT02446600
What this trial is testing

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated Carcinoma+10 more
National Cancer Institute (NCI)
Post-approval studies (Phase 4)Study completedNCT04257500
What this trial is testing

Does Vaginal Delivery of Combined Hormonal Contraception Affect the Risk of Metabolic Syndrome in Overweight/Obese Women With PCOS

Who this might be right for
Polycystic Ovary Syndrome
Andrea Roe, MD, MPH 22
Post-approval studies (Phase 4)Study completedNCT00428311
What this trial is testing

Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS

Who this might be right for
Polycystic Ovary Syndrome
Hospital Universitario Ramon y Cajal 50
Testing effectiveness (Phase 2)Study completedNCT00563836
What this trial is testing

Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer

Who this might be right for
Ovarian CancerEpithelial Ovarian Cancer
Neovii Biotech 41
Not applicableStudy completedNCT02486471
What this trial is testing

Hemostatic Procedure After Biopsy of the Cervix

Who this might be right for
Uterine Cervical Dysplasia
Zydolab - Institute of Cytology and Immune Cytochemistry 166
Not applicableWithdrawnNCT00501189
What this trial is testing

Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities

Who this might be right for
Papillomavirus Infections
Eisenhower Army Medical Center
Testing effectiveness (Phase 2)Study completedNCT00510250
What this trial is testing

A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer

Who this might be right for
Cancer of the Cervix
University Health Network, Toronto 13
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Not applicableLooking for participantsNCT06042543
What this trial is testing

Novel, One Stop, Affordable, Point of Care and AI Supported System of Screening, Triage and Treatment Selection for Cervical Cancer in LMICs

Who this might be right for
Cervical CancerScreening
International Agency for Research on Cancer 3,200
Very early researchLooking for participantsNCT06639191
What this trial is testing

[177Lu]Lu-AKIR001 First-in-human Study

Who this might be right for
Thyroid Gland Anaplastic CarcinomaPoorly Differentiated Thyroid CarcinomaCancer Head and Neck+3 more
Karolinska University Hospital 15
Not applicableStudy completedNCT01832415
What this trial is testing

First Line Ovarian Cancer Treatment - Cohort Study

Who this might be right for
Epithelial Ovarian Cancer
ARCAGY/ GINECO GROUP 500
Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Active Not RecruitingNCT06421935
What this trial is testing

M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 60
Not applicableUnknownNCT04528940
What this trial is testing

Tumor Grade Determines PD-1/PDL-1 Expression

Who this might be right for
Endometrial CancerOvarian Cancer
RWJ Barnabas Health at Jersey City Medical Center 100
Large-scale testing (Phase 3)Looking for participantsNCT06340568
What this trial is testing

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Who this might be right for
Endometrial Cancer
BioNTech SE 480
Post-approval studies (Phase 4)Study completedNCT00795808
What this trial is testing

PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene

Who this might be right for
Polycystic Ovary Syndrome
University of Auckland, New Zealand 171
Testing effectiveness (Phase 2)Study completedNCT06087289
What this trial is testing

Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Novakand Pharma AB 18
Early research (Phase 1)Looking for participantsNCT06885697
What this trial is testing

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Who this might be right for
MesotheliomaNeoplasmsStomach Neoplasms+5 more
National Cancer Institute (NCI) 100
Early research (Phase 1)Study completedNCT02146313
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic NeoplasmsOvarian Neoplasms
Genentech, Inc. 35
Next Page
579